H.G.M. Westenberg

University of Chicago — United States

Psychology · Social Sciences

16h-index1.3kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(21), Neurotransmitter Receptor Influence on Behavior(12), Mental Health Research Topics(9), Child and Adolescent Psychosocial and Emotional Development(8), Obsessive-Compulsive Spectrum Disorders(8)

Publications54 total

Erratum: Genome-wide association study of obsessive-compulsive disorder
Molecular Psychiatry·2013· 4 citedOpen Access
Impaired Neuroendocrine and Immune Response to Acute Stress in Medication-Naive Patients With a First Episode of Psychosis
Schizophrenia Bulletin·2010· 95 citedOpen Access
The Effects of Ketamine and Haloperidol on Human Selective Attention
Data Archiving and Networked Services (DANS)·2008· 1 cited
The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder
European Psychiatry·2007
No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention
Journal of Psychopharmacology·2006· 24 cited
[Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics].
PubMed·2006· 54 cited
P.4.c.001 Adjunctive quetiapine for SRI-resistant obsessive compulsive disorder: a meta-analysis of three randomised controlled treatment trials
European Neuropsychopharmacology·2006
P.3.022 The efficacy of mirtazapine in socialanxiety disorder: A double-blind placebo controlled study with adjunctive paroxetime in nonresponders to treatment
European Neuropsychopharmacology·2004
Increasing Dopaminergic Activity: Effects of L-Dopa and Bromocriptine on Human Sensory Gating
Journal of Psychopharmacology·2004· 27 cited
P.6.085 Synergistic effects of quetiapine in combination with fluvoxamine on dopamine release in rat prefrontal cortex
European Neuropsychopharmacology·2003
Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors
Acta Psychiatrica Scandinavica·2000· 216 cited
Behavioural effects of rapid i.v. challenge with meta-chlorophenylpiperazine (0.1 mg/kg) in patients with panic disorder and controls
European Neuropsychopharmacology·1999· 1 cited
Pharmacology of antidepressants: selectivity or multiplicity?
PubMed·1999· 71 cited
Clinical effects of venlafaxine in social phobia
European Neuropsychopharmacology·1998· 5 cited
Treatment options in social phobia
European Psychiatry·1998
The nature of social anxiety disorder.
PubMed·1998· 45 cited
P.3.015 Sumatriptan (5-HT1D receptor agonist) does not provoke symptoms in obsessive compulsive disorder
European Neuropsychopharmacology·1997
Biological concepts of anxiety disorders
Acta Neuropsychiatrica·1997
Panic Disorder?a Condition for Life? Treatment Issues
Human Psychopharmacology Clinical and Experimental·1997· 2 cited
Clinical Effects of Buspirone in Social Phobia
The Journal of Clinical Psychiatry·1997· 120 cited
page 1 of 3Next →

Frequent Co-authors

Johan A. den Boer(22), Irene M. van Vliet(11), Christine C. Gispen‐de Wied(4), B.R. Slaap(4), Damiaan Denys(4), Bob Oranje(3), Chantal Kemner(3), René S. Kahn(3), W.M.A. Verhoeven(3), Harold J.G.M. van Megen(3), Dan J. Stein(3), Joseph Zohar(2), K.L. Ho Pian(2), A.A. Klompmakers(2), Marinus N. Verbaten(2), D. P. Ravelli(2), J. Huisman(2), John Öhrvik(2), Irene van Vliet(2), Ron Hijman(2)